World Journal of
Pharmaceutical and Life Sciences

PRE-PANDEMIC AND POST PANDEMIC IMPACT OF COVID 19 ON THE PHARMACEUTICAL INDUSTRY

*Soumik Maity and Dr. Beduin Mahanti

ABSTRACT

As countries and industries continue to face the insurmountable challenges posed by the novel coronavirus (COVID-19), a particular concern has been the uncertainty surrounding the impact of the global COVID-19 epidemic and the chains provided to the Indian pharmaceutical business as well as to the whole world's pharmaceutical industries The COVID-19 crisis has the undeniable importance of developing a risk management plan that focuses on assessing future risks caused by the loss of a range of products between countries. This review focuses on the role of the Indian and global medical industries in the epidemic. This review examines the economic impact of COVID-19 on all segments and its implications for the Indian economy. The nineteenth-century outbreak of COVID should first open the door for Indian pharmaceutical organizations to re-operate in a supportive pharmaceutical and medium-sized trading center. The large pharmaceutical business in the Asian country has formally become the basis of affordable human services, and this pattern will now be the basis of affordable human resources. Ready to be required to raise more. Activities from COVID-19 that need to change the general perception of Indian pharmaceutical organizations and even more so, have reduced the dependence of private drug companies' organizations on sole providers such as China.

[Full Text Article]   [Download Certificate]